Feature | May 21, 2015

MRI Shows Potential to Improve Breast Cancer Risk Prediction

breast MRI, breast cancer, risk prediction, Rahbar

May 21, 2015 — Magnetic resonance imaging (MRI) provides important information about a woman’s future risk of developing breast cancer, according to a new study published in Radiology. Researchers said the findings support an expanded role for MRI in more personalized approaches to breast cancer screening and prevention.

The new study focused on the relationship between imaging features and cancer risk in women who already face a high risk of breast cancer because of family history, genetic mutations associated with the disease or other factors. In prior studies, dense breast tissue, or tissue that contains more fibroglandular tissue than fatty tissue, has been linked to an increased likelihood of breast cancer development.

“To date, it’s been difficult to assess the future risk of breast cancer for women, so there is a strong desire in the oncology community to identify ways to better determine this risk,” said study co-author Habib Rahbar, M.D., a breast imaging expert at Seattle Cancer Care Alliance and assistant professor at the University of Washington. “While breast density is loosely associated with the risk of developing breast cancer, it is unclear whether it or other imaging features can improve upon current risk assessment methods.”

Contrast-enhanced MRI is one potential tool that is already used as an imaging option to supplement mammography in high-risk women. Current American Cancer Society guidelines recommend that women with a 20 percent or greater lifetime risk of developing breast cancer undergo annual screening breast MRIs in addition to routine annual screening mammography.

In the new study, Rahbar and colleagues reviewed screening breast MR images from high-risk women 18 years or older with no history of breast cancer who were screened at their institution from January 2006 to December 2011.

The researchers looked for any associations between cancer risk and imaging features, including breast density and background parenchymal enhancement (BPE). BPE is a phenomenon in which areas of normal background breast tissue appear white, or enhanced, on the MR images. The precise reasons for this enhancement are not clear, but previous research has suggested a possible link to cancer risk.

The results showed that women who displayed elevated amounts of BPE on MRI were nine times more likely to have a breast cancer diagnosis during the study follow-up interval than those who exhibited no or minimal BPE. In contrast, mammographic density appeared to have no significant relationship to cancer risk in the study group.

The findings suggest that BPE could potentially help physicians better tailor screening and management strategies to each individual’s breast cancer risk. Currently, women at high risk for breast cancer have various options, including supplementing screening mammography with MRI, prevention therapy with tamoxifen — a drug that blocks estrogen activity in the breast — and preventive mastectomies. If validated in larger studies, BPE could provide more information to help guide these important decisions.

“MRI could be used in a broader group of women to determine who most needs supplemental screening based on their BPE levels,” Rahbar said. “This is important as we move into an era of more personalized medicine.”

The researchers are working to validate the findings in a larger group of patients and are planning additional research to understand more about why BPE may serve as a biomarker of breast cancer risk. One theory is that BPE is related to areas of inflammation associated with early stages of the disease.

“Breast cancer needs a supportive environment to grow, and recent research suggests that areas of inflammation are particularly conducive for such growth,” Rahbar said.

For more information: www.radiologyinfo.org

Related Content

News | Artificial Intelligence | November 15, 2018
Life Image and Mendel.ai announced a new strategic partnership that will facilitate the adoption and enhancement of...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery.
News | Breast Imaging | November 08, 2018
KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Feature | Breast Imaging | November 07, 2018 | By Jeff Zagoudis
Breast imaging technology has experienced major growth over the last decade or so, and a new report suggests the mark